|Bid||0.7400 x 1300|
|Ask||0.8000 x 900|
|Day's Range||0.7028 - 0.7600|
|52 Week Range||0.7000 - 15.6000|
|Beta (5Y Monthly)||2.88|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 01, 2022 - Aug 05, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.80|
At this time, I'd like to turn the conference call over to Curis' vice president of investor relations and corporate communications, Craig West. Thank you and welcome to Curis's first quarter 2022 earnings call. Joining me on today's call are Jim Dentzer, president and chief executive officer; Bill Steinkrauss, chief financial officer and chief administrative officer; Bob Martell, head of R&D. We will also be available for a question-and-answer period at the end of the call.
Curis (CRIS) delivered earnings and revenue surprises of -5.88% and 6.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Curis (CRIS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.